Table 6.
Hematological evaluation for subacute toxicity.
| Control | GTN-treated | |
|---|---|---|
| Hemoglobin (g/dL) | 155.21 ± 0.76 | 154.11 ± 1.30 |
| White blood cells (109/L) | 6.57 ± 0.21 | 6.73 ± 0.14 |
| Neutrophils (109/L) | 9.13 ± 1.23 | 10.10 ± 2.11 |
| Lymphocytes (109/L) | 77.22 ± 26.44 | 79.39 ± 21.22 |
| Monocytes (109/L) | 2.21 ± 0.21 | 2.33 ± 0.14 |
| Eosinophils (109/L) | 0.89 ± 0.90 | 0.91 ± 0.80 |
| Basophils (109/L) | 0.01 ± 0.00 | 0.01 ± 0.15 |
The results are expressed as the mean ± Standard error, (n=7). No significant difference could be detected between the GTN-treated group vs the control group. Control, the normal control group; GTN-treated, 42 mg/kg intraperitoneal GTN-treated group.